Amgen Inc. beat Wall Street estimates in the fourth quarter, as sales from newer drugs such as migraine medication Aimovig offset lower revenue from older, off-patent medications.
Carbon Health opened its latest Valley location in the NoHo West shopping center in North Hollywood, the company announced on Monday.
Calabasas biotech Turn Therapeutics has announced it received authorization to start its first human safety and efficacy trial for a COVID-19 therapy.
Sherman Oaks biopharmaceutical company T-Cure Bioscience has entered into a license agreement with Chinese biotech Immunotech Biopharm Ltd. to develop a T cell therapy for renal cancer.
California State University – Northridge will become a large-scale COVID-19 vaccination site.
The City of Lancaster, in partnership with North Carolina nonprofit Samaritan’s Purse and Antelope Valley Hospital, is building a 50-bed field hospital to serve the overwhelming number of COVID-19 patients.
Surges in COVID-19 cases linked to holiday gatherings are overwhelming Valley hospitals to the point of possibly rationing care and causing a shortage of space to store corpses.
Corinne Le Goff, a former executive at Amgen Inc., has been hired by Moderna Inc.
CommonSpirit Health, which owns Dignity Health hospitals in Northridge and Glendale, has expanded its Southwest Division.
Amgen Inc. has submitted for approval from the European Medicines Agency its drug used to treat a mutation of non-small cell lung cancer.
Staff from Valley facilities of Kaiser Permanente will participate in the health care organization’s 90-second video for “The Rose Parade’s New Year Celebration presented by Honda” on New Year’s Day.
Sterling Healthcare Logistics in Calabasas has acquired ABS Vaccines, which operates as a contract negotiator between health care providers and drug manufacturers or vendors.
Quanta Inc. in Burbank has agreed to acquire a 51 percent stake in Medolife Rx, a Wyoming company that uses patented polarization technology to make anti-viral and immune-boosting therapeutics.
Amgen Inc. has licensed one of its investigational pipeline drugs to Medicines Development for Global Health for the treatment of tuberculosis and leprosy.
The AIDS Healthcare Foundation in Los Angeles staged a socially distant protest at Amgen headquarters in Thousand Oaks in response to the biotech giant’s refusal to sell orphan drugs to nonprofit entities at a reduced price.